The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antibodies Contract Manufacturing-Global Market Insights and Sales Trends 2025
Synopsis
The global Antibodies Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibodies Contract Manufacturing in various end use industries. The expanding demands from the SME and Large Enterprise, are propelling Antibodies Contract Manufacturing market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibody Fragments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibodies Contract Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibodies Contract Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibodies Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibodies Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibodies Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibodies Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibodies Contract Manufacturing covered in this report include AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma and Lonza, etc.
The global Antibodies Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Global Antibodies Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibodies Contract Manufacturing market, Segment by Type:
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Global Antibodies Contract Manufacturing market, by Application
SME
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antibodies Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Antibodies Contract Manufacturing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Antibodies Contract Manufacturing in various end use industries. The expanding demands from the SME and Large Enterprise, are propelling Antibodies Contract Manufacturing market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Antibody Fragments segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Antibodies Contract Manufacturing market, driven by demand from China, the second largest economy with some signs of stabilising, the Antibodies Contract Manufacturing market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antibodies Contract Manufacturing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antibodies Contract Manufacturing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antibodies Contract Manufacturing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antibodies Contract Manufacturing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antibodies Contract Manufacturing covered in this report include AMRI, AGC Biologics, Aldevron, Eurofins CDMO, Boehringer Ingelheim BioXcellence, FUJIFILM Diosynth Biotechnologies, Emergent BioSolutions, KBI Biopharma and Lonza, etc.
The global Antibodies Contract Manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AMRI
AGC Biologics
Aldevron
Eurofins CDMO
Boehringer Ingelheim BioXcellence
FUJIFILM Diosynth Biotechnologies
Emergent BioSolutions
KBI Biopharma
Lonza
Novasep
Nitto Avecia Pharma Services
Pierre Fabre
Samsung BioLogics
Synthon
Thermo Fisher Scientific
Global Antibodies Contract Manufacturing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antibodies Contract Manufacturing market, Segment by Type:
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies
Global Antibodies Contract Manufacturing market, by Application
SME
Large Enterprise
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Antibodies Contract Manufacturing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Antibodies Contract Manufacturing
1.1 Antibodies Contract Manufacturing Market Overview
1.1.1 Antibodies Contract Manufacturing Product Scope
1.1.2 Antibodies Contract Manufacturing Market Status and Outlook
1.2 Global Antibodies Contract Manufacturing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Antibodies Contract Manufacturing Market Size by Region (2018-2029)
1.4 Global Antibodies Contract Manufacturing Historic Market Size by Region (2018-2023)
1.5 Global Antibodies Contract Manufacturing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Antibodies Contract Manufacturing Market Size (2018-2029)
1.6.1 North America Antibodies Contract Manufacturing Market Size (2018-2029)
1.6.2 Europe Antibodies Contract Manufacturing Market Size (2018-2029)
1.6.3 Asia-Pacific Antibodies Contract Manufacturing Market Size (2018-2029)
1.6.4 Latin America Antibodies Contract Manufacturing Market Size (2018-2029)
1.6.5 Middle East & Africa Antibodies Contract Manufacturing Market Size (2018-2029)
2 Antibodies Contract Manufacturing Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Antibody Fragments
2.1.3 Polyclonal Antibodies
2.2 Global Antibodies Contract Manufacturing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Antibodies Contract Manufacturing Historic Market Size by Type (2018-2023)
2.2.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Antibodies Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Antibodies Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Antibodies Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Antibodies Contract Manufacturing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Antibodies Contract Manufacturing Revenue Breakdown by Type (2018-2029)
3 Antibodies Contract Manufacturing Market Overview by Application
3.1 Introduction
3.1.1 SME
3.1.2 Large Enterprise
3.2 Global Antibodies Contract Manufacturing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Antibodies Contract Manufacturing Historic Market Size by Application (2018-2023)
3.2.2 Global Antibodies Contract Manufacturing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Antibodies Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Antibodies Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Antibodies Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Antibodies Contract Manufacturing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Antibodies Contract Manufacturing Revenue Breakdown by Application (2018-2029)
4 Antibodies Contract Manufacturing Competition Analysis by Players
4.1 Global Antibodies Contract Manufacturing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antibodies Contract Manufacturing as of 2022)
4.3 Date of Key Players Enter into Antibodies Contract Manufacturing Market
4.4 Global Top Players Antibodies Contract Manufacturing Headquarters and Area Served
4.5 Key Players Antibodies Contract Manufacturing Product Solution and Service
4.6 Competitive Status
4.6.1 Antibodies Contract Manufacturing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AMRI
5.1.1 AMRI Profile
5.1.2 AMRI Main Business
5.1.3 AMRI Antibodies Contract Manufacturing Products, Services and Solutions
5.1.4 AMRI Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.1.5 AMRI Recent Developments
5.2 AGC Biologics
5.2.1 AGC Biologics Profile
5.2.2 AGC Biologics Main Business
5.2.3 AGC Biologics Antibodies Contract Manufacturing Products, Services and Solutions
5.2.4 AGC Biologics Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.2.5 AGC Biologics Recent Developments
5.3 Aldevron
5.3.1 Aldevron Profile
5.3.2 Aldevron Main Business
5.3.3 Aldevron Antibodies Contract Manufacturing Products, Services and Solutions
5.3.4 Aldevron Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.3.5 Eurofins CDMO Recent Developments
5.4 Eurofins CDMO
5.4.1 Eurofins CDMO Profile
5.4.2 Eurofins CDMO Main Business
5.4.3 Eurofins CDMO Antibodies Contract Manufacturing Products, Services and Solutions
5.4.4 Eurofins CDMO Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.4.5 Eurofins CDMO Recent Developments
5.5 Boehringer Ingelheim BioXcellence
5.5.1 Boehringer Ingelheim BioXcellence Profile
5.5.2 Boehringer Ingelheim BioXcellence Main Business
5.5.3 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Products, Services and Solutions
5.5.4 Boehringer Ingelheim BioXcellence Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.5.5 Boehringer Ingelheim BioXcellence Recent Developments
5.6 FUJIFILM Diosynth Biotechnologies
5.6.1 FUJIFILM Diosynth Biotechnologies Profile
5.6.2 FUJIFILM Diosynth Biotechnologies Main Business
5.6.3 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Products, Services and Solutions
5.6.4 FUJIFILM Diosynth Biotechnologies Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.6.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.7 Emergent BioSolutions
5.7.1 Emergent BioSolutions Profile
5.7.2 Emergent BioSolutions Main Business
5.7.3 Emergent BioSolutions Antibodies Contract Manufacturing Products, Services and Solutions
5.7.4 Emergent BioSolutions Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.7.5 Emergent BioSolutions Recent Developments
5.8 KBI Biopharma
5.8.1 KBI Biopharma Profile
5.8.2 KBI Biopharma Main Business
5.8.3 KBI Biopharma Antibodies Contract Manufacturing Products, Services and Solutions
5.8.4 KBI Biopharma Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.8.5 KBI Biopharma Recent Developments
5.9 Lonza
5.9.1 Lonza Profile
5.9.2 Lonza Main Business
5.9.3 Lonza Antibodies Contract Manufacturing Products, Services and Solutions
5.9.4 Lonza Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.9.5 Lonza Recent Developments
5.10 Novasep
5.10.1 Novasep Profile
5.10.2 Novasep Main Business
5.10.3 Novasep Antibodies Contract Manufacturing Products, Services and Solutions
5.10.4 Novasep Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.10.5 Novasep Recent Developments
5.11 Nitto Avecia Pharma Services
5.11.1 Nitto Avecia Pharma Services Profile
5.11.2 Nitto Avecia Pharma Services Main Business
5.11.3 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Products, Services and Solutions
5.11.4 Nitto Avecia Pharma Services Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.11.5 Nitto Avecia Pharma Services Recent Developments
5.12 Pierre Fabre
5.12.1 Pierre Fabre Profile
5.12.2 Pierre Fabre Main Business
5.12.3 Pierre Fabre Antibodies Contract Manufacturing Products, Services and Solutions
5.12.4 Pierre Fabre Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.12.5 Pierre Fabre Recent Developments
5.13 Samsung BioLogics
5.13.1 Samsung BioLogics Profile
5.13.2 Samsung BioLogics Main Business
5.13.3 Samsung BioLogics Antibodies Contract Manufacturing Products, Services and Solutions
5.13.4 Samsung BioLogics Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.13.5 Samsung BioLogics Recent Developments
5.14 Synthon
5.14.1 Synthon Profile
5.14.2 Synthon Main Business
5.14.3 Synthon Antibodies Contract Manufacturing Products, Services and Solutions
5.14.4 Synthon Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.14.5 Synthon Recent Developments
5.15 Thermo Fisher Scientific
5.15.1 Thermo Fisher Scientific Profile
5.15.2 Thermo Fisher Scientific Main Business
5.15.3 Thermo Fisher Scientific Antibodies Contract Manufacturing Products, Services and Solutions
5.15.4 Thermo Fisher Scientific Antibodies Contract Manufacturing Revenue (US$ Million) & (2018-2023)
5.15.5 Thermo Fisher Scientific Recent Developments
6 North America
6.1 North America Antibodies Contract Manufacturing Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Antibodies Contract Manufacturing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Antibodies Contract Manufacturing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Antibodies Contract Manufacturing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Antibodies Contract Manufacturing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Antibodies Contract Manufacturing Market Dynamics
11.1 Antibodies Contract Manufacturing Industry Trends
11.2 Antibodies Contract Manufacturing Market Drivers
11.3 Antibodies Contract Manufacturing Market Challenges
11.4 Antibodies Contract Manufacturing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
